The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

5 Dec 2016 07:00

RNS Number : 8838Q
Standard Life Euro Pri Eqty Tst PLC
05 December 2016
 

5 December 2016

STANDARD LIFE EUROPEAN PRIVATE EQUITY TRUST PLC

RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2016

Highlights

· The Company's net asset value total return for the year ended 30 September 2016 was 24.8%. Following a strategic review the Board is proposing changes to the investment policy, the dividend policy and fee arrangements, details of which are provided below.

 

· Net asset value per ordinary share ("NAV") at 30 September 2016 rose 23.0% to 346.4p (30 September 2015 - 281.6p). The increase in NAV during the period included 14.9% of net realised gains and income from the Company's portfolio of 49 private equity fund interests, 3.8% of unrealised losses on a constant exchange rate basis, 13.1% of positive exchange rate movements on the portfolio, and the payment of dividends during the year ended 30 September 2016.

 

· Actual NAV of 346.4p compares to a previously estimated NAV at 30 September 2016 of 338.9p announced on 14 October 2016. Closing mid-market price of the Company's ordinary shares on 30 September 2016 was 267.3p, an increase of 24.9% over the year and a discount of 22.8% to NAV.

 

· Recommended final dividend of 3.6p per ordinary share, which together with the interim dividend of 1.8p paid in July 2016, makes a total for the year of 5.4p (year ended 30 September 2015 - 5.25p). The Board intends to increase the annual dividend, for the year ending 30 September 2017, to 12.0p per share. The Board is committed to maintaining the real value of this new enhanced dividend and growing it at least in line with inflation, in the absence of unforeseen circumstances.

 

· At the year end the Company's net assets were £532.6 million. In preparing the Company's year end valuation, 98.7% by value of the portfolio was valued by the relevant fund manager at 30 September 2016.

 

· Distributions received by, and draw downs from, the portfolio during the year were £126.9 million and £66.2 million respectively. In addition, the Company acquired through the secondary market one private equity fund interest for £19.1 million.

 

· During the year the Company acquired a total of 2,030,000 ordinary shares through a series of share buy-back transactions for £4.5 million. The ordinary shares were acquired at an average price of 221.6p and at an average discount to the prevailing NAV of 29.4%. The ordinary shares acquired have been cancelled.

 

· The Company had liquid resources of £105.9 million at 30 September 2016. In addition, the Company has an undrawn £80 million syndicated revolving credit facility, provided by Citibank and Societe Generale that expires in December 2020.

 

· The Company made three new fund commitments during the year, with commitments of €45.0 million to Advent International GPE VIII, €28.1 million to the Sixth Cinven Fund and €23.0 million to Astorg VI. In addition, the Company assumed outstanding commitments of £10.4 million on the secondary acquisition of TowerBrook Investors III.

 

· The Company had £305.9 million of outstanding commitments at 30 September 2016. After undertaking a detailed review, the Manager continues to believe that up to £55 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

· During the period from 30 September 2016 to 1 December 2016 the Company received distributions of £14.4 million and funded £7.4 million of draw downs.

 

· At 1 December 2016 the Company had a cash balance of £111.0 million and outstanding commitments of £325.1 million.

 

· A new commitment of €34.0 million was made to IK VIII in October 2016.

 

· Although the returns generated by the Company have been strong, its shares have persistently traded at a discount to its net asset value. As detailed in the Company's circular and the Chairman's Statement, the Board is proposing changes to the Company's investment policy to remove the current size and geographic restrictions on private equity investments. Notwithstanding, the majority of the portfolio will retain a European focus.

 

· In addition, to maximise the returns on cash held pending investment in private equity funds, a product of the Company's over-commitment strategy, the Board is also proposing to broaden the investment policy in regard to cash management to incorporate listed direct private equity investments, to be utilised opportunistically in suitably liquid investment companies.

 

· To reflect the proposed changes, to be voted on by shareholders at the Company's Annual General Meeting on 24 January 2017, the Board is recommending to shareholders that they approve a change in the name of the Company to Standard Life Private Equity Trust PLC.

 

· The Company's Manager has been incentivised by a success-based performance fee. The performance fee had a set five-year life which expired at the end of the last financial year. The strong growth in the Company's value meant that the Manager exceeded the agreed performance hurdle and triggered a payment under the performance fee scheme of £6.4 million.

 

· The Board is in the process of finalising new fee arrangements with the Manager and has negotiated the adoption of a single annual management fee of 0.95% of the net asset value of the Company, to replace the previous management fee and incentive fee arrangement. The Board believe the new fee structure delivers value for shareholders.

 

 

For further information please contact:-

Roger Pim and Peter McKellar of SL Capital Partners LLP (on 0131 245 0055)

 

 

CHAIRMAN'S STATEMENT

 

This has been a year of strong growth for the Company. Buoyant company valuations driven by strong underlying trading and a fall in the value of sterling have combined to outweigh any immediate effect of the UK referendum vote to exit the European Union ("Brexit"). Your Company's net asset value produced a total return of 24.8% during the year to the end of September and its share price delivered a total return including dividends of 27.9%. By contrast, the MSCI Europe Index delivered a total return of 20.2% over the same period.

 

Much of the past year has been dominated by the Brexit process. The pound has fallen by 14.8% against the euro as investors have faced up to the prospect of prolonged uncertainty about the economic, industrial and political implications of the referendum, not only in Britain but across Europe. Although equity markets have proven resilient, which has had a positive impact on the comparative valuations of the unlisted companies in the Company's portfolio, there have already been some indications that the uncertainty is affecting corporate activity.

 

Although political and economic uncertainty persists, making predictions as to the future prospects of the corporate sector especially hard at present, your Board continues to believe that the best private equity managers will continue to generate strong positive returns for investors over the long term and that the Company is uniquely well positioned to capture these returns for investors.

 

It is reassuring, in these circumstances, that the Company's portfolio has continued to benefit from strong underlying trading and a positive flow of realisations as companies it is invested in are sold by the managers of the funds that make up the portfolio. In the year to September, these realisations totalled £126.9 million compared to £106.7 million in the prior year. Against this, £66.2 million was drawn down from the Company's resources to fund investee companies. This compares to £63.1 million in the previous year.

 

As a result of the strong net cash flow from the portfolio, the Manager, SL Capital Partners, has worked hard to ensure that the Company's resources are deployed efficiently. The Manager has continued to make new commitments to high quality funds which will deploy cash over the coming years and build value for the future and has increased the Company's focus on acquiring fund positions in the secondary market. At times, the Manager has deployed a proportion of the Company's cash pending investment in private equity funds in equity index tracker funds. While the capability is maintained, given the current market uncertainties the Company currently holds no such investments. The net effect is that, as at the end of September, the Company had net liquid resources of £105.9 million, up from £69.4 million a year before, and total outstanding commitments to make future investments of £305.9 million, compared to £245.8 million previously.

 

SL Capital Partners has been incentivised by a success-based incentive fee. The incentive fee had a set five year life which expired at the end of the financial year. The strong growth in the Company's value meant that the Manager exceeded the agreed performance hurdle, and triggered a payment under the incentive fee scheme of £6.4 million.

 

The Board is in the process of finalising new fee arrangements with the Manager and has negotiated the adoption of a single management fee of 0.95% of net asset value to replace the previous management fee and incentive fee. The Board believes the new fee structure delivers value for shareholders.

 

Although the returns generated by the Company have been strong, its shares have persistently traded at a discount to its net asset value. As at the end of September this discount was 22.8%, and it averaged 26.7% through the year. Although this phenomenon is consistent with the Company's private equity investment trust peer group, it is a frustration to the Board and we regularly assess opportunities to address the scale of the discount. We have used the opportunity afforded by a high discount to buy back 2,030,000 of the Company's shares for cancellation during the year. The average discount on these buybacks was 29.4%.

 

Furthermore, the Board believes that providing a strong, stable dividend is attractive to shareholders. To that end, the decision has been taken to increase the annual dividend to 12.0 pence per share, for the year ending 30 September 2017, equating to a yield of approximately 3.5% on net asset value per ordinary share. The Board is committed to maintaining the real value of this new enhanced dividend and growing it at least in line with inflation, in the absence of unforeseen circumstances. In line with the current dividend policy, the Board has proposed a final dividend, for the year ended 30 September 2016, of 3.6 pence per share equating to an annual dividend of 5.4 pence per share.

 

Following an in depth strategic review, the Board has also concluded that it would be beneficial to increase the private equity opportunity set available to the Manager, by removing the current size restrictions and broadening the geographic reach on private equity investments in the Company's investment policy. In addition, to maximise the returns on cash held pending investment in private equity funds, a product of the Company's over-commitment strategy, the Board recommends broadening the investment policy in regard to cash management to incorporate listed direct private equity investments, to be utilised opportunistically in suitably liquid investment companies. The Board is proposing at the Annual General Meeting that shareholders approve the requisite amendments to the investment policy to action these changes.

 

The key outcome of these changes is that the Manager will be able to invest in the leading private equity buyout funds regardless of size and with additional geographic freedom, thereby enhancing the overall exposure to the private equity asset class. The intention is to increase the private equity opportunity set without diluting the strategy and focus. Shareholders should not expect a radical shift in the composition of the Company's portfolio, which will remain conviction oriented with a European focus.

 

The Board believes that the combination of changes outlined above should, over time, help deliver strong returns to shareholders and enhance the attractiveness of the Company to new investors. Finally, to reflect this and the broader investment universe available to the Manager, the Board is recommending a change in the Company's name to Standard Life Private Equity Trust PLC.

 

Details of these proposed changes will be included in the circular distributed with the Report and Financial Statements.

 

 

Edmond Warner, OBE

Chairman

 

2 December 2016

 

PRINCIPAL RISKS AND UNCERTAINTIES

 

The principal risks facing the Company relate to the Company's investment activities and include the following:

 

• market risk;

• currency risk;

• over-commitment risk;

• liquidity risk;

• credit risk;

• interest rate risk; and

• operating and control environment risk

Information on each of these risks, and an explanation of how they are managed, is contained in the Company's Annual Report.

 

 

 

DIRECTORS' RESPONSIBILITY STATEMENT

 

 

The directors are responsible for preparing the Annual Report, the Directors' Remuneration Report and the financial statements in accordance with applicable law and regulations

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have prepared the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Generally Accepted Accounting Practice), including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period. In preparing these financial statements, the directors are required to:

 

· select suitable accounting policies and then apply them consistently;

· make judgements and accounting estimates that are reasonable and prudent;

· state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements respectively; and

· prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business .

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements and the Directors' Remuneration Report comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

The directors consider that the annual report and accounts, taken as a whole, is fair, balanced and understandable and provides the information necessary for shareholders to assess the Company's position and performance, business model and strategy. In reaching this conclusion the directors have assumed that the reader of the annual report and accounts has a reasonable level of knowledge of the investment industry.

 

The directors are responsible for the maintenance and integrity of the Company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Each of the directors confirm that, to the best of their knowledge:

 

· the financial statements, which have been prepared in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Generally Accepted Accounting Practice), including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and applicable law, give a true and fair view of the assets, liabilities, financial position and profit of the Company as at 30 September 2016;

· the directors' report includes a fair review of the development and performance of the business and the position of the Company, together with a description of the principal risks and uncertainties that it faces; and

· the Annual Report and Financial Statements, taken as a whole is fair, balanced and understandable and provides the information necessary to assess the Company's position and performance, business model and strategy.

 

For Standard Life European Private Equity Trust PLC

 

Edmond Warner OBE

Chairman

2 December 2016

 

 

 

 

 

 

 

 

 

STATEMENT OF COMPREHENSIVE INCOME (audited)

for the year ended 30 September 2016

 

Revenue

Capital

Total

£'000

£'000

£'000

Total capital gains on investments

-

100,041

100,041

Currency gains

-

8,727

8,727

Income

10,655

-

10,655

Investment management fee

(396)

(3,563)

(3,959)

Incentive fee

-

(6,447)

(6,447)

Administrative expenses

(806)

-

(806)

_________

_________

_________

Profit on ordinary activities

before finance costs and taxation

9,453

98,758

108,211

Finance costs

(130)

(657)

(787)

_________

_________

_________

Profit on ordinary activities

before taxation

9,323

98,101

107,424

Taxation

(2,207)

1,434

(773)

_________

_________

_________

Net profit on ordinary activities

after taxation

7,116

99,535

106,651

_________

_________

_________

Net profit per ordinary share

4.59p

64.15p

68.74p

_________

_________

_________

 

 

The Total column of this statement represents the profit and loss account of the Company.

 

There are no items of other comprehensive income, therefore this statement is the single statement of comprehensive income of the Company.

All revenue and capital items in the above statement are derived from continuing operations.

 

No operations were acquired or discontinued in the year.

 

The dividend which has been recommended based on this Income Statement is 5.4p (2015 - 5.25p) per ordinary share.

 

 

 

 

 

 

 

 

 

STATEMENT OF COMPREHENSIVE INCOME (audited)

for the year ended 30 September 2015

 

Revenue

Capital

Total

£'000

£'000

£'000

Total capital gains on investments

-

40,346

40,346

Currency gains

-

495

495

Income

11,917

-

11,917

Investment management fee

(342)

(3,082)

(3,424)

Incentive fee

-

-

-

Administrative expenses

(715)

-

(715)

_________

_________

_________

Profit on ordinary activities

before finance costs and taxation

10,860

37,759

48,619

Finance costs

(127)

(1,141)

(1,268)

_________

_________

_________

Profit on ordinary activities

before taxation

10,733

36,618

47,351

Taxation

(1,784)

1,627

(157)

_________

_________

_________

Net profit on ordinary activities

after taxation

8,949

38,245

47,194

_________

_________

_________

Net profit per ordinary share

5.69p

24.35p

30.04p

_________

_________

_________

 

 

 

 

 

 

 

 

 

 

 

 

 

STATEMENT OF CHANGES IN EQUITY (audited)

 

For the year ended30 September 2016

 

Share

Capital

Share

premium

Special

redemption

Capital

Revenue

capital

account

reserve

reserve

reserves

reserve

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 1 October 2015

312

86,485

56,024

89

280,380

15,450

438,740

Profit on ordinary activities after taxation

-

-

-

-

99,535

7,116

106,651

Buy back of ordinary shares

(5)

-

(4,521)

5

-

-

(4,521)

Dividends paid

-

-

-

-

-

(8,238)

(8,238)

______

_______

______

_______

________

_______

_______

Balance at 30 September 2016

307

86,485

51,503

94

379,915

14,328

532,632

______

_______

______

_______

________

_______

_______

For the year ended30 September 2015

 

Share

Capital

Share

premium

Special

redemption

Capital

Revenue

capital

account

reserve

reserve

reserves

reserve

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 1 October 2014

318

86,485

62,947

83

242,135

17,134

409,102

Profit on ordinary activities after taxation

-

-

-

-

38,245

8,949

47,194

Buy back of ordinary shares

(6)

-

(6,923)

6

-

-

(6,923)

Dividends paid

-

-

-

-

-

(10,633)

(10,633)

______

_______

______

_______

________

_______

_______

Balance at 30 September 2015

312

86,485

56,024

89

280,380

15,450

438,740

______

_______

______

_______

________

_______

_______

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

STATEMENT OF FINANCIAL POSITION (audited)

 

As at

As at

30 September

30 September

2016

2015

£'000

£'000

£'000

£'000

Non-current assets

Investments

433,392

406,332

Current assets

Receivables

774

729

Cash and cash equivalents

105,883

32,099

_________

_________

106,657

32,828

Creditors: amounts falling

due within one year

Payables

(7,417)

(420)

_________

_________

Net current assets

99,240

32,408

_________

_________

Total assets less current liabilities

532,632

438,740

_________

_________

Capital and reserves

Called up share capital

307

312

Share premium

86,485

86,485

Special reserve

51,503

56,024

Capital redemption reserve

94

89

Capital reserves

379,915

280,380

Revenue reserve

14,328

15,450

_________

_________

Total shareholders' funds

532,632

438,740

_________

_________

Net asset value per equity share

346.4p

281.6p

_________

_________

 

 

 

 

 

 

 

STATEMENT OF CASHFLOWS (audited)

 

 

 

For the year

For the year

ended 30 September

ended 30 September

as re-stated

2016

2015

£'000

£'000

£'000

£'000

Cash flows from operating activities

Net profit on ordinary activities after taxation

106,651

47,194

Adjusted for:

Finance costs

787

1,268

Taxation

773

157

Gains on disposal of investments

(57,595)

(29,636)

Revaluation of investments

(42,446)

(10,710)

Currency gains on cash balances and money market funds

(8,727)

(495)

Loan interest receivable

(9,107)

(10,160)

Dividends receivable

(2,155)

(2,797)

Loan interest received

9,107

10,160

Dividends received

2,155

2,797

(Increase)/decrease in debtors

(15)

4

Increase in creditors

7,000

235

Tax deducted from non - UK income

(773)

(157)

UK Corporation Tax paid

(200)

-

Interest paid

(620)

(822)

Loan arrangement fee paid

-

(690)

_________

_________

 

Net cash inflow from operating activities

4,835

6,348

_________

_________

Investing activities

Purchase of investments

(85,540)

(106,307)

Disposal of underlying investments by funds

158,521

106,283

Disposal of fund investments by way of secondary sales

-

21,661

_________

_________

Net cash inflow from investing activities

72,981

21,637

Financing activities

Buy back of ordinary shares

(4,521)

(7,323)

Ordinary dividends paid

(8,238)

(10,633)

_________

_________

 

 

Net cash outflow from financing activities

 

(12,759)

 

(17,956)

_________

_________

 

Cash and cash equivalents at the end of the year

 

65,057

 

10,029

 

Cash and cash equivalents at the beginning of the year

 

32,099

 

21,575

Currency gains on cash and cash equivalents

8,727

495

_________

_________

 

Cash and cash equivalents at the end of the year

 

105,883

 

32,099

_________

_________

Cash and cash equivalent consists of:

Money market funds

45,934

-

Cash and short term deposits

59,949

32,099

_________

_________

 

Cash and cash equivalents

 

105,883

 

32,099

_________

_________

 

 

Notes:

 

1. Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the London Stock Exchange. It seeks to conduct its affairs so as to continue to qualify as an investment trust under section 1158-1165 of the Corporation Taxes Act 2010. The Board is wholly independent of the Manager and Standard Life plc.

 

2. Accounting Policies

(a) Basis of accounting

The financial statements have been prepared in accordance with the Companies Act 2006, Financial Reporting Standard 102 and with the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts'. They have also been prepared on the assumption that approval as an investment trust will continue to be granted. The financial statements have been prepared on a going concern basis.

 

These financial statements are the first since FRS 102 (The Financial Reporting Standard applicable in the UK and Republic of Ireland) came into effect for accounting periods beginning on or after 1 January 2015. The impact of adopting FRS 102 did not require any restatement of balances as at the transition date, 1 October 2014, or comparative figures in the Statement of Financial Position or the Statement of Comprehensive Income. The Company has chosen to early adopt the Amendments to FRS 102, paragraph 34.22 which revise the disclosure requirements for financial institutions, specifically in relation to the fair value hierarchy. These amendments were approved for issue on 3 March 2016 and are effective for accounting periods beginning on or after 1 January 2017.

(b) Revenue, expenses and finance costs

 

Dividends from quoted investments are included in revenue by reference to the date on which the price is marked ex-dividend. Income on quoted investments and other interest receivable are dealt with on an accruals basis. Dividends and income from unquoted investments are included when the right to receipt is established. Dividends are accounted for as Income from investments in the Statement of Comprehensive Income. All expenses are accounted for on an accruals basis. Incentive fees are recognised in the Statement of Comprehensive Income as they are earned and when the return exceeds the specified hurdle rate.

 

 

All expenses are accounted for on an accruals basis. Expenses are charged through the revenue account of the Statement of Comprehensive Income except as follows:

 

 

 - transaction costs incurred on the purchase and disposal of investments are recognised as a capital item in the Statement of Comprehensive Income;

 

 

 - the Company charges 90% of investment management fees and finance costs to capital, in accordance with the Board's expected long- term split of returns between capital gains and income from the Company's investment portfolio. Bank interest paid has arisen as a consequence of negative interest rates on Euro cash balances and has been charged wholly to revenue; and

 

 

 - any incentive fees payable are allocated wholly to capital, as they are expected to be attributable largely, if not wholly, to capital performance.

 

(c) Investments

 

Investments have been designated upon initial recognition as fair value through profit or loss. On the date of making a legal commitment to invest in a fund, such commitment is recorded and disclosed. When funds are drawn in respect of such fund commitment the resulting investment is recognised in the financial statements. The investment is removed when it is realised or the fund is wound up. Subsequent to initial recognition, investments are valued at fair value as detailed below. Gains and losses arising from changes in fair value are included in net profit or loss for the period as a capital item in the Statement of Comprehensive Income and are ultimately recognised in the capital reserves.

 

 

 

 

Unquoted investments are stated at the directors' estimate of fair value and follow the recommendations of the EVCA and the BVCA. The estimate of fair value is normally the latest valuation placed on a fund by its manager as at the Statement of Financial Position date. The valuation policies used by the manager in undertaking that valuation will generally be in line with the joint publication from the EVCA and the BVCA, 'International Private Equity and Venture Capital Valuation guidelines'. Where formal valuations are not completed as at the Statement of Financial Position date the last available valuation from the fund manager is adjusted for any subsequent cash flows occurring between the valuation date and the Statement of Financial Position date. The Company's Manager may further adjust such valuations to reflect any changes in circumstances from the last manager's formal valuation date to arrive at the estimate of fair value.

For listed investments, fair value is deemed to be bid market prices or closing prices for SETS stocks sourced from the London Stock Exchange. SETS is the London Stock Exchange electronic trading service.

 

(d) Dividends payable

Interim and final dividends are recognised in the period in which they are paid. Scrip dividends are recognised in the period in which shares are issued.

(e) Capital reserves

Share premium - The share premium account represents the premium above nominal value received by the Company on issuing shares net of issue costs.

Special reserve - Court approval was given on 27 September 2001 for 50% of the initial premium arising on the issue of the ordinary share capital to be cancelled and transferred to a special reserve. The reserve is a distributable reserve and may be applied in any manner as a distribution, other than by way of a dividend.

Capital reserves - Gains or losses on investments realised in the year that have been recognised in the Statement of Comprehensive Income are transferred to the "capital reserve - gains/(losses) on disposal". In addition, any prior unrealised gains or losses on such investments are transferred from the "capital reserve - revaluation" to the "capital reserve - gains/(losses) on disposal" on the disposal of the investment. Increases and decreases in the fair value of investments are recognised in the Statement of Comprehensive Income and are then transferred to the "capital reserve - revaluation".

Revenue reserve - The revenue reserve represents accumulated revenue profits retained by the Company that have not currently been distributed to shareholders as a dividend.

(f) Taxation

 

i) Current taxation - Provision for corporation tax is made at the current rate on the excess of taxable income net of any allowable deductions.

 

 

ii) Deferred taxation is recognised in respect of all timing differences that have originated but not reversed at the Statement of Financial Position date, where transactions or events that result in an obligation to pay more or a right to pay less tax in future have occurred at the Statement of Financial Position date, measured on an undiscounted basis and based on enacted tax rates. This is subject to deferred tax assets only being recognised if it is considered more likely than not that there will be suitable profits from which the future reversal of the underlying timing differences can be deducted. Timing differences are differences arising between the Company's taxable profits and its results as stated in the accounts which are capable of reversal in one or more subsequent periods.

 

 

 

 

Due to the Company's status as an investment trust company, and the intention to continue meeting the conditions required to obtain approval in the foreseeable future, the Company has not provided deferred tax on any capital gains and losses arising on the revaluation or disposal of investments.

 

(g) Overseas currencies

Overseas assets and liabilities are translated at the exchange rate prevailing at the Company's Statement of Financial Position date. Gains or losses on translation of investments held at the year end are accounted for through the Statement of Comprehensive Income and transferred to capital reserves. Gains or losses on the translation of overseas currency balances held at the year end are also accounted for through the Statement of Comprehensive Income and transferred to capital reserves.

 

 

 

 

 

Rates of exchange to sterling as at 30 September were:

 

 

 

 

2016

2015

 

 

Euro

1.1559

1.3570

 

 

US dollar

1.2990

1.5148

 

 

 

 

Transactions in overseas currency are translated at the exchange rate prevailing on the date of transaction.

 

 

 

(h) Judgements and key sources of estimation uncertainty

The preparation of financial statements requires the Company to make estimates and assumptions and exercise judgements in applying the accounting policies that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses arising during the year. Estimates and judgements are continually evaluated and based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. The area where estimates and assumptions have the most significant effect on the amounts recognised in the financial statements is the determination of fair value of unquoted investments, as disclosed in note 1(c).

(i) Cash and cash equivalents

Cash comprises bank balances and cash held by the Company. Cash equivalents comprise AAA money market funds which are used by the Company to provide additional short-term liquidity. Cash equivalents are short term, highly liquid investments that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value.

Year to

Year to

30 September 2016

30 September 2015

3.

Income

£'000

£'000

Income from fund investments

10,338

11,065

Income from index tracker funds

306

836

Income from cash balances and money market funds

 

11

 

16

______________

______________

Total income

10,655

11,917

______________

______________

4.

Investment management and incentive fees

Year to 30 September 2016

Year to 30 September 2015

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 Investment management fee

396

3,563

3,959

342

3,082

3,424

 Incentive fee

-

6,447

6,447

-

-

______

_______

______

_______

________

_______

396

10,010

10,406

342

3,082

3,424

______

_______

______

_______

________

_______

 

The investment management fee payable to the Manager is 0.8% per annum of the investments and other assets of the Company and any subsidiaries less the aggregate of the liabilities of the Company and any subsidiaries. The investment management fee is allocated 90% to the realised capital reserve and 10% to the revenue account. The management agreement between the Company and the Manager is terminable by either party on twelve months written notice.

 

The Manager is also entitled to an incentive fee at 30 September 2016. For an incentive fee to be payable, the Company's net asset value total return must grow by more than 8% compound per annum (before any accrual for the incentive fee) over the five year period to 30 September 2016. The Manager is entitled to an incentive fee of 10% of the growth in NAV (before any accrual for the incentive fee) in excess of the hurdle rate, multiplied by the number of ordinary shares in issue on 1 October 2011 (adjusted in certain circumstances to reflect subsequent share issuance and/or a material reduction in the Company's issued share capital). At 30 September 2016 the net asset value total return was 371.0p and had exceeded the 8% per annum compound growth hurdle at the same date of 331.9p.

 

 

 

 

 

5.

Investments

30 September 2016

30 September 2015

Index

tracker

funds

£'000

Fund

Investments

£'000

Total

£'000

Index

tracker

funds

£'000

Index

tracker

funds

£'000

Total

£'000

Fair value through profit or loss:

Opening market value

37,339

368,993

403,332

39,161

348,462

387,623

Opening investment holding losses

1,817

32,258

37,075

395

47,390

47,785

______

_______

______

_______

________

_______

Opening book cost

39,156

404,251

443,407

39,556

395,852

435,408

Movements in the year:

Additions at cost

-

66,193

66,193

9,000

96,522

105,522

Secondary purchases

-

19,099

19,099

-

-

-

Dividends reinvested

248

-

248

785

-

785

Disposal of underlying investments by funds

(41,384)

(117,137)

(158,521)

(10,500)

(95,783)

(106,283)

Disposal of fund investments by way of secondary sales

-

-

-

-

(21,661)

(21,661)

______

_______

______

_______

________

_______

(1,980)

372,406

370,426

38,841

374,930

413,771

Gains on disposal of underlying investments

1,980

56,172

58,152

315

40,725

41,040

Losses on liquidation of fund investments

-

(557)

(557)

-

(11,966)

(11,966)

Gains on disposal of fund investments by way of secondary sales

-

-

-

-

562

562

______

_______

______

_______

________

_______

Closing book cost

-

428,021

428,021

39,156

404,251

443,407

Closing investment holding gains/(losses)

-

5,371

5,371

(1,817)

(35,258)

(37,075)

______

_______

______

_______

________

_______

 Closing market value

-

433,392

433,392

37,339

368,993

406,332

30 September 2016

30 September 2015

Index

tracker

funds

£'000

Fund

Investments

£'000

Total

£'000

Index

tracker

funds

£'000

Index

tracker

funds

£'000

Total

£'000

Gains on investments:

Net gains on disposal of investments

1,980

55,615

57,595

315

29,321

29,636

Net revaluation of investments

1,817

40,629

42,446

(1,422)

12,132

10,710

______

_______

______

_______

________

_______

3,797

96,244

100,041

(1,107)

41,453

40,436

Transaction costs

During the year expenses were incurred in acquiring or disposing of investments. These have been expensed through capital and are included within gains on investments in the Statement of Comprehensive Income. The total costs were as follows:

30 September 2016

30 September 2016

£'000

£'000

Purchases in respect of unquoted fund investments

30

147

Secondary sales

-

30

________

_______

30

177

 

 

 

5. The return per ordinary share figure is based on the net profit for the year ended 30 September 2016 of £105,115,000 (year ended 30 September 2015: net profit of £47,194,000) and on 155,155,447 (year ended 30 September 2015: 157,081,338) ordinary shares, being the weighted average number of Ordinary shares in issue during the respective periods.

 

6. The number of ordinary shares in issue as at 30 September 2016 was 153,746,294 (30 September 2015 - 155,776,294).

 

7. An interim dividend of 1.80p (2015 - 1.75p) per ordinary share was paid on 15 July 2016. The Directors recommend that a final dividend of 3.6p (2015 - 3.5p) per ordinary share be paid on 27 January 2017 to shareholders on the Company's share register as at the close of business on 23 December 2016.

 

8.  The financial information set out in this announcement does not constitute statutory financial statements within the meaning of Section 435 of the Companies Act 2006 in respect of the financial statements for the year ended 30 September 2016. The statutory financial statements for the year ended 30 September 2015, upon which the Company's auditors have given a report that was unqualified and did not contain a statement under either section 498(2) or section 498(3) of the Companies Act 2006, have been delivered to the Registrar of Companies.

 

The financial information in this announcement is consistent with that in the audited statutory financial statements for the year ended 30 September 2016. The contents of the announcement have been extracted from the audited financial statements that have been approved and signed by the directors and upon which the auditor has signed an unqualified auditor's report. The audited financial statements for the year ended 30 September 2016 will be delivered to the Registrar of Companies following the Company's Annual General Meeting, which will be held at The Balmoral Hotel, 1 Princes Street, Edinburgh EH2 2EQ on 24 January 2017 at 12.30pm.

 

9. The report and accounts for the year ended 30 September 2016 will be posted to shareholders in mid-December 2016 and copies will be available from the Company Secretary - Maven Capital Partners UK LLP, Kintyre House, 205 West George Street, Glasgow, G2 2LW.

 

for Standard Life European Private Equity Trust PLC,

Maven Capital Partners UK LLP, Company Secretary

 

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR UUSBRNOAURAA
Date   Source Headline
4th Apr 202212:06 pmRNSChange of Name
22nd Mar 20222:14 pmRNSResult of AGM
21st Mar 202211:26 amRNSDirector Declaration
14th Mar 20225:30 pmRNSFTSE Russell Indices
14th Mar 20227:00 amRNSEstimated NAV at 28 February 2022
9th Mar 20222:07 pmRNSFirst Interim Dividend
24th Feb 20227:00 amRNSEdison review on Standard Life Private Equity Trst
14th Feb 20227:00 amRNSEstimated NAV at 31 January 2022
4th Feb 20223:24 pmRNSAnnual Report
1st Feb 202212:45 pmRNSDirector/PDMR Shareholding
27th Jan 20227:05 amRNSEstimated NAV at 31 December 2021
27th Jan 20227:00 amRNSAnnual Financial Report
6th Jan 20229:04 amRNSQuarterly disclosure
15th Dec 20217:00 amRNSEstimated NAV as at 30 November 2021
14th Dec 20213:48 pmRNSFourth Interim Dividend
6th Dec 20217:00 amRNSEdison review on Standard Life Private Equity Trst
12th Nov 20217:00 amRNSEstimated NAV at 31 October 2021
2nd Nov 20214:25 pmRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSEstimated NAV at 30 September 2021
4th Oct 20214:15 pmRNSQuarterly disclosure
29th Sep 20217:02 amRNSEstimated NAV at 31 August 2021
29th Sep 20217:00 amRNSQuarterly Investment Update at 30 June 2021
17th Sep 20211:10 pmRNSUpdate research from QuotedData
7th Sep 20217:00 amRNSThird Interim Dividend
1st Sep 20217:00 amRNSDirectorate Change
16th Aug 202110:19 amRNSDirector/PDMR Shareholding
13th Aug 20217:00 amRNSEstimated NAV at 31 July 2021
10th Aug 20214:41 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
5th Aug 20213:32 pmRNSDirector/PDMR Shareholding
19th Jul 202111:58 amRNSEdison issues review on Standard Life Private
14th Jul 20219:05 amRNSDirector Declaration
14th Jul 20217:00 amRNSEstimated NAV at 30 June 2021
9th Jul 20213:29 pmRNSDoc re. Half yearly report
2nd Jul 20214:35 pmRNSQuarterly disclosure
29th Jun 20217:05 amRNSEstimated NAV at 31 May 2021
29th Jun 20217:00 amRNSHalf-year Report
14th Jun 20212:48 pmRNSSecond Interim Dividend
17th May 20217:00 amRNSEstimated NAV at 30 April 2021
12th May 20214:06 pmRNSDirector/PDMR Shareholding
27th Apr 202112:21 pmRNSDirector/PDMR Shareholding
22nd Apr 20217:05 amRNSEstimated NAV at 31 March 2021
22nd Apr 20217:00 amRNSQuarterly Investment Update at 31 December 2020
9th Apr 202111:58 amRNSHolding(s) in Company
6th Apr 20214:11 pmRNSQuarterly disclosure
23rd Mar 20211:50 pmRNSResult of AGM
12th Mar 20217:00 amRNSEstimated NAV as at 28 February 2021
8th Mar 20217:00 amRNSFirst Interim Dividend
25th Feb 20217:00 amRNSEdison review on Standard Life Private Eqty Trust
12th Feb 202110:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.